IP Verse

Mylan Technologies, Inc. et al. vs Noven Pharmaceuticals, Inc. et al.

The detailed information for PTAB case with proceeding number IPR2018-00174 filed by Mylan Technologies, Inc. et al. against Noven Pharmaceuticals, Inc. et al. on Dec 4, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2018-00174
Filing Date: Dec 4, 2017
Petitioner: Mylan Technologies, Inc. et al.
Respondent: Noven Pharmaceuticals, Inc. et al.
Status: Terminated-Settled
Respondent Application Number: 13553972
Respondent Tech Center: 1600
Respondent Patent Number: 9730900
Institution Decision Date: Jun 12, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice of Refund	Nov 23, 2018	PAPER	BOARD
Petitioner's Request for Refund	Oct 26, 2018	PAPER	PETITIONER
Order - 37 C.F.R. 42.5	Sep 28, 2018	PAPER	BOARD
Joint Motion to Expunge Exhibit 2024 Under 37 C.F.R. Section 42.56	Sep 26, 2018	PAPER	PATENT OWNER
DECISION Granting Joint Motion to Terminate Proceeding 35 U.S.C. § 317; 37 C.F.R. §§ 42.72, 42.74	Sep 13, 2018	PAPER	BOARD
Joint Request to Treat Binding Term Sheet (EX2024) as Business Confidential Information	Sep 5, 2018	PAPER	PATENT OWNER
Patent Owner's Updated Exhibit List as of September 5, 2018	Sep 5, 2018	PAPER	PATENT OWNER
Joint Motion to Terminate Proceedings	Sep 5, 2018	PAPER	PATENT OWNER
EXPUNGED	Sep 5, 2018	EXHIBIT	PATENT OWNER
Patent Owner Opposition to Request for Rehearing	Jul 20, 2018	PAPER	PATENT OWNER
Petitioner Mylan Technologies, Inc.'s Request for Rehearing	Jul 12, 2018	PAPER	PETITIONER
Trial Instituted Document	Jun 12, 2018	PAPER	BOARD
Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8	Jun 7, 2018	PAPER	PATENT OWNER
J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery	Mar 13, 2018	EXHIBIT	PATENT OWNER
A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin	Mar 13, 2018	EXHIBIT	PATENT OWNER
K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption	Mar 13, 2018	EXHIBIT	PATENT OWNER
Esclim Product Label	Mar 13, 2018	EXHIBIT	PATENT OWNER
A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs	Mar 13, 2018	EXHIBIT	PATENT OWNER
A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems	Mar 13, 2018	EXHIBIT	PATENT OWNER
R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin	Mar 13, 2018	EXHIBIT	PATENT OWNER
J. Mantelle, DOT Matrix Technology	Mar 13, 2018	EXHIBIT	PATENT OWNER
J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study	Mar 13, 2018	EXHIBIT	PATENT OWNER
Patent Owner Preliminary Response	Mar 13, 2018	PAPER	PATENT OWNER
Declaration of Dr. Adrian C. Williams	Mar 13, 2018	EXHIBIT	PATENT OWNER
Curriculum Vitae of Dr. Adrian C. Williams	Mar 13, 2018	EXHIBIT	PATENT OWNER
Minivelle Product Label	Mar 13, 2018	EXHIBIT	PATENT OWNER
J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery	Mar 13, 2018	EXHIBIT	PATENT OWNER
B. Barry, Transdermal Drug Delivery	Mar 13, 2018	EXHIBIT	PATENT OWNER
J. Mantelle, et al., Effect of Silicone/Acrylic PSA Blends on Skin Permeation	Mar 13, 2018	EXHIBIT	PATENT OWNER
A. Williams & B. Barry, Chemical Permeation Enhancement	Mar 13, 2018	EXHIBIT	PATENT OWNER
K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems	Mar 13, 2018	EXHIBIT	PATENT OWNER
Google Scholar search results obtained March 7, 2018, citations of Kim et al., Penetration Enhancement of B2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin	Mar 13, 2018	EXHIBIT	PATENT OWNER
U.S. Patent No. 8,029,820	Mar 13, 2018	EXHIBIT	PATENT OWNER
B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models	Mar 13, 2018	EXHIBIT	PATENT OWNER
J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin	Mar 13, 2018	EXHIBIT	PATENT OWNER
R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan	Mar 13, 2018	EXHIBIT	PATENT OWNER
R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil	Mar 13, 2018	EXHIBIT	PATENT OWNER
Petitioner's Mandatory Change-of-Information Notices	Dec 29, 2017	PAPER	PETITIONER
Patent Owner Mandatory Notices	Dec 21, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Dec 14, 2017	PAPER	BOARD
EX1011 US Patnt No. 5,656,286 to Miranda	Dec 4, 2017	EXHIBIT	PETITIONER
EX1016 Alora - Document #5210490A	Dec 4, 2017	EXHIBIT	PETITIONER
EX1027 US Patent No. 5,352,457 to Jenkins	Dec 4, 2017	EXHIBIT	PETITIONER
EX1029 US Pat Pub 20060078601 to Kanios	Dec 4, 2017	EXHIBIT	PETITIONER
EX1001 US 9,730,900 to Mantelle	Dec 4, 2017	EXHIBIT	PETITIONER
EX1003 Brain CV	Dec 4, 2017	EXHIBIT	PETITIONER
EX1004 US 9,730,900 File History Part 1 of 2	Dec 4, 2017	EXHIBIT	PETITIONER
EX1004 US 9,730,900 File History Part 2 of 2	Dec 4, 2017	EXHIBIT	PETITIONER
EX1005 US Pat Pub 20030099695 to Mueller	Dec 4, 2017	EXHIBIT	PETITIONER
EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B	Dec 4, 2017	EXHIBIT	PETITIONER
EX1007 US Pat Pub 20060078602 to Kanios	Dec 4, 2017	EXHIBIT	PETITIONER
EX1008 Vivelle Label FOI Affidavit and Doc 5210567A	Dec 4, 2017	EXHIBIT	PETITIONER
EX1009 US Patent No. 5,145,682 to Chien	Dec 4, 2017	EXHIBIT	PETITIONER
EX1010 Kim	Dec 4, 2017	EXHIBIT	PETITIONER
EX1012 WO 1996003119 to Fotinos	Dec 4, 2017	EXHIBIT	PETITIONER
EX1013 US Patent No. 5,919,477 to Bevan	Dec 4, 2017	EXHIBIT	PETITIONER
EX1014 Ghosh	Dec 4, 2017	EXHIBIT	PETITIONER
EX1015 Climara - Document #5243107A	Dec 4, 2017	EXHIBIT	PETITIONER
EX1017 Menostar - Document #5228320A	Dec 4, 2017	EXHIBIT	PETITIONER
EX1018 US Patent No. 5,902,602 to Muller	Dec 4, 2017	EXHIBIT	PETITIONER
EX1019 US Patent No. 6,156,335 to Rovati	Dec 4, 2017	EXHIBIT	PETITIONER
EX1020 US Patent No. 6,521,250 to Meconi	Dec 4, 2017	EXHIBIT	PETITIONER
EX1021 US Patent No. 5,227,169 to Heiber	Dec 4, 2017	EXHIBIT	PETITIONER
EX1022 Bucks	Dec 4, 2017	EXHIBIT	PETITIONER
EX1023 Dinger - Noven Pharmaceuticals, Inc	Dec 4, 2017	EXHIBIT	PETITIONER
EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape	Dec 4, 2017	EXHIBIT	PETITIONER
EX1025 van der Bijl	Dec 4, 2017	EXHIBIT	PETITIONER
EX1026 Bronaugh	Dec 4, 2017	EXHIBIT	PETITIONER
EX1028 US Patent No. 5,603,947 to Wong	Dec 4, 2017	EXHIBIT	PETITIONER
EX1030 US Patent No. 6,638,528 to Kanios	Dec 4, 2017	EXHIBIT	PETITIONER
EX1031 US Patent No. 4,624,665 to Nuwayser	Dec 4, 2017	EXHIBIT	PETITIONER
EX1032 US Pat Pub 20090041831 to Miller	Dec 4, 2017	EXHIBIT	PETITIONER
EX1033 US Patent No. 6,024,976 to Miranda	Dec 4, 2017	EXHIBIT	PETITIONER
EX1034 The Orange Book	Dec 4, 2017	EXHIBIT	PETITIONER
Power of Attorney	Dec 4, 2017	PAPER	PETITIONER
EX1002 Declaration of Keith Brain, Ph.D	Dec 4, 2017	EXHIBIT	PETITIONER
Petition for Inter Partes Review of US 9730900	Dec 4, 2017	PAPER	PETITIONER